首页 产品目录 分子砌块 按官能团 酰胺类 (1R,2S,5S)-N-(4-氨基-1-环丁基-3,4-二氧代丁-2-基)-3-((S)-2-(3-(叔丁基)脲基)-3,3-二甲基丁酰基)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲酰胺

(1R,2S,5S)-N-(4-氨基-1-环丁基-3,4-二氧代丁-2-基)-3-((S)-2-(3-(叔丁基)脲基)-3,3-二甲基丁酰基)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲酰胺

(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-(tert-butyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
1g 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

394730-60-0

中文名称

(1R,2S,5S)-N-(4-氨基-1-环丁基-3,4-二氧代丁-2-基)-3-((S)-2-(3-(叔丁基)脲基)-3,3-二甲基丁酰基)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲酰胺

英文名称

(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-(tert-butyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

别名

Boceprevir (1R,2S,5S)-N-(4-Amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;Boceprevir, >=98%;Boceprevir;(1R,2S,5S)-N-(4-Amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;EBP 520;Sch 503034;EBP 520;SCH 503034;EBP-520;EBP520;SCH-503034;SCH503034);CS-354

标准英文名

(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-(tert-butyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

分子式

C27H45N5O5

分子量

519.34

精确分子量

519.34

SMILES

NC(C(C(CC1CCC1)NC([C@@H]2[C@]3([H])[C@@](CN2C([C@H](C(C)(C)C)NC(NC(C)(C)C)=O)=O)([H])C3(C)C)=O)=O)=O

标准SMILES

CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C

用途

Boceprevir is an orally administered hepatitis C virus (HCV) NS3/4A serine protease inhibitor used for the treatment of chronic hepatitis C (genotype 1) infection. It is indicated for use in combination with peginterferon alfa and ribavirin in adult patients (≥18 years) with compensated liver disease, including cirrhosis, who are either treatment-naïve or have failed prior therapy with interferon and ribavirin. Boceprevir exerts its antiviral effect by directly binding to the NS3/4A protease active site, thereby inhibiting viral replication. It is also noted as a research compound related to novel coronavirus studies.

InChIKey

LHHCSNFAOIFYRV-DOVBMPENSA-N

安全信息

SureRoute逆合成路线

1.  394730-60-0 逆合成路线 1

—
—
ACJFYJ373
394730-60-0
来源: SureRoute

2.  394730-60-0 逆合成路线 2

—
—
ACJFYJ373
394730-60-0
来源: SureRoute

3.  394730-60-0 逆合成路线 3

—
—
—
—
ACJFYJ373
394730-60-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手